12 unchanged sentences
Giordano joined the Company as our Chief Executive Officer and a member of our Board of Directors in July 2021 and became President and Chief Executive Officer in October 2021.
−Removed: From March 2018 to July 2021, he served as President of IQVIA Biotech LLC and IQVIA MedTech Inc., a provider of integrated clinical and commercial solutions to smaller biotech companies, where he led an executive team that executed a clinical trial portfolio that grew from 250 to 400 active projects during his three years of leadership.
+Added: From March 2018 to July 2021, he served as President of IQVIA Biotech LLC and IQVIA MedTech Inc., a provider of integrated clinical and commercial solutions to medical device and small biotech companies, where he led an executive team that managed a clinical trial portfolio that grew from 250 to 400 active projects during his three years of leadership.
Prior to that role, from August 2008 to March 2018, Mr.
2 unchanged sentences
From January 2001 to July 2008, Mr.
−Removed: Giordano served in various sales and management roles at PPD, Inc., a global clinical research organization.
+Added: Giordano served in various sales and operational roles at PPD, Inc., a global clinical research organization.
Giordano holds a B.A.
−Removed: in English from University of San Diego and a M.A.
+Added: ( summa cum laude ) in English from the University of San Diego and a M.A.
in English from the University of North Carolina at Chapel Hill.
16 unchanged sentences
in Accounting from Syracuse University and is a Certified Public Accountant in Massachusetts.
−Removed: Stuart Rich has served as our Chief Medical Officer since January 2021 and a director since February 2021.
+Added: Stuart Rich, MD has served as our Chief Medical Officer since January 2021 and a director since February 2021.
Rich joined the Company from PHPM, where he was a co-founder and held the positions of Chief Executive Officer and Director from October 2018 until PHPM’s merger with the Company in January 2021.
−Removed: Since July 2015, Dr.
−Removed: Rich has served as Professor of Medicine at Northwestern University Feinberg School of Medicine and as Director of the Pulmonary Vascular Disease Program at the Bluhm Cardiovascular Institute, a U.K.
−Removed: based charity, and since January 2011, he has also served as Director of the Cardiovascular Medical and Research Foundation, a U.S.
+Added: Beginning July 2015, Dr.
+Added: Rich has served as Professor of Medicine (and since 2021, Professor Emeritus) at Northwestern University Feinberg School of Medicine.
+Added: He was co-founder and a Trustee of the Pulmonary Vascular Research Institute from 2006 until 2013, a U.K.
based charity.
+Added: Since July 2015, he has also served as a Director of the Pulmonary Vascular Disease Program at the Bluhm Cardiovascular Institute, a U.K.
+Added: based charity, and since January 2011, he has served as Director of the Cardiovascular Medical and Research Foundation, a U.S.
+Added: based charity.
+Added: He was a standing member of the Cardiovascular and Renal Advisory Committee of the U.S.
+Added: Food and Drug Administration from 2002 through 2013.
Prior to Northwestern University, Dr.
6 unchanged sentences
Louis and his fellowship in cardiology at the University of Chicago.
+Added: Proehl , Director and Chairman
+Added: Founder, President, Chief Executive Officer and Chair of the Board of Directors, Dermata Therapeutics, Inc.
+Added: June Almenoff, MD, PhD , Director
+Added: Chief Medical Officer, RedHill Biopharma Inc.
+Added: Michael Davidson, MD , Director
+Added: Chief Executive Officer, New Amsterdam Pharma B.V.
+Added: Declan Doogan, MD , Director
+Added: Co-founder and Chief Medical Officer, Juvenescence Ltd.
+Added: Christopher T.
+Added: Giordano , Chief Executive Officer, President and Director
+Added: Tenax Therapeutics, Inc.
+Added: Hunter , Director
+Added: Global Chief Financial Officer, Sotio Biotech Inc.
+Added: Stuart Rich, MD , Chief Medical Officer and Director
+Added: Tenax Therapeutics, Inc.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.